Biochemistry Quiz: Lipoproteins And Lipid Transport

What this quiz covers

This quiz focuses on Lipoproteins And Lipid Transport, giving you a quick way to practice the rules, question types, and explanations that matter most for Biochemistry.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

Question 1

1. An increase in HDL cholesterol and a decrease in LDL cholesterol levels. (correct answer)
2. A decrease in both HDL cholesterol and VLDL triacylglycerol levels.
3. A significant rise in chylomicron levels due to impaired peripheral clearance.
4. An increase in the rate of VLDL secretion from the liver and a subsequent rise in LDL.

Explanation: When you encounter questions about lipid transport proteins, focus on understanding the specific role each protein plays in moving lipids between different lipoproteins. CETP facilitates the transfer of cholesteryl esters from HDL to apoB-containing lipoproteins (VLDL and LDL) in exchange for triacylglycerols. This process normally reduces HDL cholesterol levels while increasing cholesterol content in VLDL and LDL particles. When CETP is inhibited, this transfer is blocked. Without functional CETP, cholesteryl esters remain in HDL particles, leading to increased HDL cholesterol levels. Simultaneously, less cholesterol is transferred to VLDL and LDL, resulting in decreased LDL cholesterol levels. This makes option A correct. Option B is wrong because CETP inhibition would actually increase HDL cholesterol (not decrease it), and while VLDL composition might change, total VLDL levels aren't the primary effect. Option C incorrectly focuses on chylomicrons, which are primarily involved in dietary fat transport and aren't the main target of CETP activity. Option D suggests increased VLDL secretion, but CETP inhibition affects lipid transfer between existing lipoproteins rather than stimulating new lipoprotein synthesis or secretion from the liver. For biochemistry exams, remember that transport proteins like CETP act as "shuttles" moving specific components between lipoproteins. When these shuttles are blocked, think about where the transported material gets "stuck" - this will help you predict the resulting changes in lipoprotein composition.

Question 2

1. increased transcription of the HMG-CoA reductase gene and increased expression of LDL receptors on the cell surface.
2. allosteric inhibition of HMG-CoA reductase and decreased transcription of the gene for the LDL receptor. (correct answer)
3. activation of the LCAT enzyme to esterify the excess cholesterol and export it from the cell via HDL.
4. upregulation of scavenger receptors to facilitate the removal of excess cholesterol-laden LDL from the cytoplasm.

Explanation: High intracellular cholesterol levels initiate a coordinated response to prevent further accumulation. This involves: 1) Decreasing de novo cholesterol synthesis by inhibiting HMG-CoA reductase (the rate-limiting enzyme) and reducing its gene transcription. 2) Reducing cholesterol uptake from the circulation by decreasing the synthesis of new LDL receptors. 3) Increasing cholesterol storage by activating acyl-CoA:cholesterol acyltransferase (ACAT) to esterify it. Option B correctly identifies the first two key negative feedback events.

Question 3

1. Accumulation of chylomicrons in the plasma due to incomplete triacylglycerol hydrolysis.
2. Reduced secretion of triacylglycerol-rich VLDL particles from the liver.
3. An increase in the plasma concentration of intermediate-density lipoprotein (IDL). (correct answer)
4. Enhanced uptake of LDL by peripheral tissues via the LDL receptor.

Explanation: In the endogenous pathway, VLDL is converted to IDL by lipoprotein lipase (LPL). Hepatic lipase (HL) is then involved in the final conversion of IDL to LDL by hydrolyzing remaining triacylglycerols and phospholipids. If HL is inhibited, this final conversion step is blocked, leading to an accumulation of the precursor, IDL, in the circulation.

Question 4

1. A significant reduction in the synthesis of triacylglycerols within hepatocytes, leading to low VLDL levels.
2. Impaired binding and uptake of LDL particles by peripheral tissues due to a lack of receptor recognition.
3. Marked elevation of triacylglycerol-rich lipoproteins, specifically chylomicrons and VLDL, in the plasma. (correct answer)
4. Accelerated clearance of chylomicron remnants by the liver, resulting in unusually low levels of circulating lipids after a meal.

Explanation: ApoC-II is a crucial activator of lipoprotein lipase (LPL), the enzyme responsible for hydrolyzing triacylglycerols in both chylomicrons (from the diet) and VLDL (from the liver). Without functional ApoC-II, LPL activity is severely diminished, preventing the breakdown of these particles. This leads to their accumulation in the plasma, causing severe hypertriglyceridemia, which is especially prominent in the fed state when chylomicrons are present.

Question 5

1. Native LDL particles via the LDL receptor (LDLR), which becomes overexpressed in macrophages.
2. Oxidized LDL particles via scavenger receptors, which are not subject to feedback inhibition by cholesterol. (correct answer)
3. VLDL particles via the VLDL receptor, leading to massive triacylglycerol accumulation in macrophages.
4. Chylomicron remnants via the LRP-1 receptor, depositing dietary cholesterol directly into the subendothelial space.

Explanation: A key event in atherogenesis is the modification of LDL, particularly through oxidation, in the subendothelial space. Macrophages do not readily take up native LDL. However, they express scavenger receptors (e.g., SR-A, CD36) that recognize and internalize modified or oxidized LDL. Crucially, unlike the LDL receptor, scavenger receptors are not downregulated by high intracellular cholesterol. This leads to uncontrolled uptake of oxidized LDL, massive cholesterol accumulation, and the transformation of macrophages into lipid-laden foam cells.

Question 6

1. Reduced secretion of VLDL particles from the liver, leading to low plasma triacylglycerol levels.
2. Normal secretion of VLDL from the liver, but elevated plasma concentrations of LDL due to impaired clearance. (correct answer)
3. Increased activity of lipoprotein lipase, leading to rapid conversion of VLDL to LDL and low VLDL levels.
4. Elevated plasma HDL concentrations as a compensatory mechanism for the defective LDL pathway.

Explanation: ApoB-100 has two key roles: structural integrity for VLDL/IDL/LDL and acting as the ligand for the LDL receptor. The question states that VLDL assembly/secretion is normal, so the liver will produce and secrete VLDL at a typical rate. VLDL will be converted to IDL and then to LDL in circulation. However, because the ApoB-100 on the resulting LDL particle cannot bind to the LDL receptor, clearance of LDL from the blood is severely impaired, leading to high plasma LDL levels.

Question 7

1. The liver and intestine fail to synthesize and secrete the primary HDL apolipoprotein, ApoA-I.
2. Cholesterol cannot be esterified within nascent HDL, preventing the formation of a nonpolar core and maturation into spherical HDL. (correct answer)
3. Cholesteryl ester transfer protein (CETP) becomes hyperactive, rapidly depleting the HDL particles of their lipid content.
4. The ABCA1 transporter cannot effectively load free cholesterol from peripheral cells onto the nascent HDL particles.

Explanation: LCAT, activated by ApoA-I, is the enzyme that esterifies free cholesterol collected by nascent HDL from peripheral tissues. This esterification traps the hydrophobic cholesteryl ester in the core of the lipoprotein, allowing more free cholesterol to be taken up. This process is essential for the maturation of the small, nascent HDL discs into larger, spherical HDL particles (HDL3 and HDL2). Without LCAT, this maturation fails, and the unstable nascent particles are rapidly cleared from circulation, resulting in very low HDL levels.

Question 8

1. The activation of lipoprotein lipase for triglyceride hydrolysis and the activation of LCAT for cholesterol esterification.
2. The assembly of chylomicrons in enterocytes and the structural integrity of VLDL particles secreted from the liver.
3. The hepatic clearance of chylomicron remnants via the remnant receptor and the clearance of IDL particles. (correct answer)
4. The binding of native LDL to its receptor on peripheral cells and the efflux of cholesterol from macrophages to HDL.

Explanation: ApoE serves as a high-affinity ligand for receptors in the liver that are responsible for clearing remnant particles from circulation. Specifically, it mediates the binding and endocytosis of chylomicron remnants (after they have been acted upon by LPL) and intermediate-density lipoproteins (IDL), the remnants of VLDL catabolism. A lack of functional ApoE would therefore impair the clearance of both types of remnants, leading to their accumulation.

Question 9

1. Post-translational proteolytic cleavage of the full-length ApoB-100 protein by an intestine-specific protease.
2. Alternative splicing of the pre-mRNA transcript, which removes the exons coding for the C-terminal half of the protein.
3. Use of an alternative, downstream transcription start site in intestinal cells, resulting in a shorter initial transcript.
4. Site-specific deamination of a cytosine to a uracil in the mRNA transcript, creating a premature stop codon. (correct answer)

Explanation: The production of ApoB-48 from the same gene as ApoB-100 is a classic example of tissue-specific mRNA editing. In intestinal enterocytes, an enzyme complex deaminates a specific cytidine nucleotide (C) in the mRNA to a uridine (U). This changes a CAA codon, which codes for glutamine, into a UAA codon, which is a stop codon. This results in the translation of a truncated protein that is approximately 48% of the length of the full ApoB-100 protein synthesized in the liver.

Question 10

1. Very-low-density lipoproteins (VLDL) carrying endogenously synthesized lipids.
2. Low-density lipoproteins (LDL) delivering cholesterol to the liver for bile acid synthesis.
3. Chylomicron remnants, which are depleted of triacylglycerols but still rich in dietary cholesterol. (correct answer)
4. Mature high-density lipoproteins (HDL) completing the final step of reverse cholesterol transport.

Explanation: Dietary fats are transported from the intestine in chylomicrons. In circulation, lipoprotein lipase removes most of the triacylglycerols for use by peripheral tissues. The resulting particle, smaller and denser, is called a chylomicron remnant. These remnants, which still contain dietary cholesterol, cholesteryl esters, and fat-soluble vitamins, are specifically cleared from the circulation by receptors on hepatocytes.

Question 11

1. Chylomicrons, which are the largest and least dense lipoproteins.
2. Very-low-density lipoproteins (VLDL), which primarily transport endogenous triacylglycerols.
3. Low-density lipoproteins (LDL), which are the primary carriers of cholesterol to peripheral tissues.
4. High-density lipoproteins (HDL), which are involved in reverse cholesterol transport. (correct answer)

Explanation: Lipoprotein density is inversely related to lipid content and directly related to protein content. HDL is the smallest and most dense of the lipoproteins, containing the highest percentage of protein (around 40-55%) and the lowest percentage of lipid. In contrast, chylomicrons are the least dense and are almost entirely lipid (1-2% protein). VLDL and LDL have intermediate compositions, with VLDL being richer in lipid than LDL. After a 12-hour fast, chylomicrons from the diet would be absent or at very low levels.

Question 12

1. To export fatty acids, mobilized from adipose tissue and synthesized de novo, to tissues like muscle for β-oxidation. (correct answer)
2. To deliver dietary fatty acids that were stored in the liver to peripheral tissues for energy.
3. To transport cholesterol to steroidogenic tissues for the synthesis of stress hormones like cortisol.
4. To clear excess triacylglycerols from the blood that have accumulated due to lack of dietary intake.

Explanation: When analyzing VLDL metabolism during fasting, focus on the liver's role as a metabolic hub that redistributes energy substrates to meet the body's needs when glucose is scarce. During prolonged fasting, your body shifts from glucose to fat as its primary fuel source. The liver becomes central to this metabolic transition by packaging fatty acids into VLDL particles for export. These fatty acids come from two main sources: mobilization from adipose tissue stores (delivered to the liver as free fatty acids) and de novo synthesis within hepatocytes themselves. The liver then assembles these fatty acids into triacylglycerols, packages them with apolipoproteins into VLDL particles, and secretes them into circulation. Muscle and other peripheral tissues can then extract these fatty acids for β-oxidation, generating the ATP needed to sustain cellular function when glucose availability is limited. Option B is incorrect because during fasting, dietary fatty acid stores would already be depleted after 24 hours—the liver is mobilizing endogenous fat stores, not dietary remnants. Option C misidentifies the primary purpose; while VLDL does carry some cholesterol, its main cargo during fasting is energy-providing fatty acids, not cholesterol for steroidogenesis. Option D contradicts the actual metabolic situation—blood triacylglycerol levels aren't elevated from dietary excess during fasting, and VLDL synthesis actually increases rather than clears circulating lipids. Remember that VLDL function changes dramatically between fed and fasted states. In fasting, think "energy export system" rather than "lipid storage vehicle."

Question 13

1. specific apolipoproteins embedded in its surface monolayer, which are required for secretion and metabolism. (correct answer)
2. a higher relative content of cholesteryl esters compared to triacylglycerols in its core.
3. a surrounding phospholipid bilayer membrane, whereas a lipid droplet has only a monolayer.
4. a core composed exclusively of dietary lipids, whereas lipid droplets store only endogenously synthesized lipids.

Explanation: When you encounter questions comparing different lipid-containing structures, focus on their key structural and functional differences, particularly what enables their specific biological roles. Chylomicrons and intracellular lipid droplets both store neutral lipids (primarily triacylglycerols) in their cores, but they serve very different functions. Chylomicrons must travel through the bloodstream to deliver dietary lipids to tissues, while lipid droplets remain within cells for local storage. This functional difference requires distinct structural features. The defining characteristic of chylomicrons is their surface apolipoproteins - specialized proteins like apoB-48, apoC-II, and apoE that are embedded in their phospholipid monolayer surface. These apolipoproteins are essential for chylomicron assembly, secretion from intestinal cells, recognition by lipoprotein lipase for triglyceride hydrolysis, and uptake by target tissues. Lipid droplets lack these apolipoproteins entirely. Choice B is incorrect because both structures contain predominantly triacylglycerols, not cholesteryl esters as their major component. Choice C misrepresents the membrane structure - both have phospholipid monolayers surrounding their neutral lipid cores, not bilayers. Choice D oversimplifies lipid origins; while chylomicrons do transport dietary lipids, lipid droplets can store both dietary-derived and endogenously synthesized lipids. For biochemistry exams, remember that lipoproteins are distinguished by their apolipoprotein composition, which determines their metabolic fate. The presence and type of apolipoproteins is what allows lipoproteins to function in lipid transport, unlike simple intracellular storage structures.

Question 14

1. Increased HDL cholesterol levels and decreased LDL cholesterol levels due to blocked lipid transfer (correct answer)
2. Decreased HDL cholesterol levels and increased LDL triglyceride content due to blocked lipid exchange
3. No change in lipoprotein profiles because CETP only affects intracellular cholesterol metabolism
4. Increased chylomicron levels because CETP is required for their hepatic clearance

Explanation: When you encounter questions about lipid metabolism proteins like CETP, focus on understanding what each protein does and how inhibiting it affects the normal flow of lipids between lipoproteins. CETP (cholesteryl ester transfer protein) facilitates the transfer of cholesteryl esters from HDL to apoB-containing lipoproteins (like LDL and VLDL) in exchange for triglycerides. Think of CETP as a molecular shuttle that moves cholesteryl esters from "good" HDL particles to "bad" LDL particles. When you block this shuttle with an inhibitor, cholesteryl esters remain trapped in HDL particles, making them larger and more cholesterol-rich, while LDL particles receive fewer cholesteryl esters and become smaller and less atherogenic. Choice A correctly describes this outcome: HDL cholesterol levels increase because cholesteryl esters can't leave HDL particles, and LDL cholesterol levels decrease because fewer cholesteryl esters are transferred to LDL. Choice B is backwards—HDL cholesterol would increase, not decrease, when transfer is blocked. Choice C incorrectly suggests CETP works intracellularly, when it actually functions in plasma to transfer lipids between different lipoprotein particles. Choice D confuses CETP's role with other proteins involved in chylomicron metabolism; CETP doesn't directly affect chylomicron clearance. Remember that CETP inhibitors have been developed as potential cardiovascular drugs precisely because blocking cholesteryl ester transfer raises HDL and can lower LDL—though clinical outcomes have been mixed, demonstrating that higher HDL doesn't always translate to better cardiovascular protection.

Question 15

1. Normal VLDL secretion because MTP only affects chylomicron assembly in the intestine
2. Increased VLDL secretion due to compensatory upregulation of alternative lipid transfer mechanisms
3. Severely impaired VLDL secretion despite increased hepatic triglyceride synthesis (correct answer)
4. Enhanced VLDL secretion because MTP normally inhibits lipoprotein assembly

Explanation: MTP is essential for the assembly of apoB-containing lipoproteins in both the liver (VLDL) and intestine (chylomicrons). It transfers lipids to apoB during lipoprotein assembly. Without functional MTP, the liver cannot properly assemble and secrete VLDL particles, even though triglyceride synthesis may be increased during fasting. This leads to hepatic steatosis. Choice A is incorrect because MTP functions in both liver and intestine. Choice B is wrong because there are no adequate alternative mechanisms. Choice D reverses MTP's actual function.

Question 16

1. Population A would have higher LDL cholesterol because PCSK9 normally promotes LDL receptor degradation
2. Population B would have lower LDL cholesterol because PCSK9 gain-of-function enhances cholesterol synthesis
3. No difference would be observed because PCSK9 primarily affects HDL metabolism
4. Population A would have lower LDL cholesterol because PCSK9 loss-of-function preserves LDL receptors (correct answer)

Explanation: When you encounter questions about PCSK9, focus on its role as a regulator of LDL receptor availability. PCSK9 is a protein that binds to LDL receptors on liver cells and promotes their degradation, effectively reducing the cell's ability to remove LDL cholesterol from the bloodstream. Population A has loss-of-function PCSK9 mutations, meaning their PCSK9 protein works poorly or not at all. Without functional PCSK9 to degrade them, LDL receptors persist on liver cell surfaces much longer. More LDL receptors means more efficient removal of LDL cholesterol from blood, resulting in lower LDL cholesterol levels. This makes answer D correct. Answer A reverses the logic entirely. While it correctly states that PCSK9 promotes LDL receptor degradation, it incorrectly concludes that Population A (loss-of-function) would have higher LDL cholesterol. Less PCSK9 activity actually preserves more receptors and lowers LDL. Answer B misunderstands PCSK9's mechanism. PCSK9 doesn't directly affect cholesterol synthesis - it regulates receptor-mediated cholesterol clearance. Gain-of-function mutations would actually increase LDL cholesterol by destroying more receptors. Answer C is factually wrong. PCSK9 primarily affects LDL metabolism, not HDL metabolism, and the populations would definitely show differences in LDL levels. Remember this pathway: PCSK9 ↑ → LDL receptors ↓ → LDL cholesterol ↑. Loss-of-function mutations break this chain early, while gain-of-function mutations amplify it. PCSK9 inhibitors are now major cholesterol medications based on this exact mechanism.

Question 17

1. Inability to transport dietary lipids from intestine and endogenous lipids from liver (correct answer)
2. Defective reverse cholesterol transport due to impaired HDL particle formation
3. Accumulation of cholesteryl esters in peripheral tissues due to blocked efflux pathways
4. Enhanced lipoprotein lipase activity leading to severe hypotriglyceridemia in plasma

Explanation: ApoB is the essential structural protein for both chylomicrons (apoB-48) and VLDL/LDL (apoB-100). Without apoB, patients cannot assemble or secrete these lipoproteins, preventing transport of dietary fats from the intestine and endogenous lipids from the liver. Choice B is incorrect because HDL formation depends on apoA-I, not apoB. Choice C is wrong because the problem is inability to transport lipids out of tissues, not into them. Choice D is incorrect because lipoprotein lipase would have no substrate to act upon without apoB-containing lipoproteins.

Question 18

1. Increased synthesis of VLDL particles by the liver due to compensatory mechanisms
2. Accumulation of cholesterol-rich LDL particles in the plasma due to impaired cellular uptake (correct answer)
3. Decreased activity of lipoprotein lipase leading to elevated triglyceride levels
4. Enhanced reverse cholesterol transport from peripheral tissues to the liver

Explanation: Defective LDL receptors directly impair the receptor-mediated endocytosis of LDL particles by cells, particularly hepatocytes. This leads to accumulation of cholesterol-rich LDL in the plasma because the particles cannot be efficiently removed from circulation. Choice A is incorrect because VLDL synthesis is not directly affected by LDL receptor defects. Choice C is wrong because lipoprotein lipase acts on VLDL and chylomicrons, not LDL. Choice D is incorrect because reverse cholesterol transport involves HDL, not LDL receptors.

Question 19

1. Increased risk of pancreatitis due to severe hypertriglyceridemia from impaired lipoprotein lipase activity
2. Enhanced reverse cholesterol transport leading to protection against atherosclerosis
3. Increased atherothrombotic risk due to both atherogenic and prothrombotic properties (correct answer)
4. Improved glucose metabolism due to enhanced insulin sensitivity in peripheral tissues

Explanation: Lp(a) contains apolipoprotein(a) linked to apoB-100, giving it both atherogenic properties (like LDL) and prothrombotic properties (due to structural similarity of apo(a) to plasminogen, which can interfere with fibrinolysis). This makes elevated Lp(a) a significant cardiovascular risk factor. Choice A is incorrect because Lp(a) doesn't cause hypertriglyceridemia. Choice B is wrong because Lp(a) is atherogenic, not protective. Choice D is incorrect because Lp(a) doesn't directly affect glucose metabolism.

Question 20

1. ApoB-48 is transferred to HDL particles while apoC-II and apoE remain on the remnant
2. ApoC-II and apoC-III are transferred to HDL while apoB-48 and apoE remain on the remnant (correct answer)
3. All apolipoproteins except apoB-48 are degraded by lipoprotein lipase during triglyceride hydrolysis
4. ApoE is synthesized de novo on the remnant particle to facilitate hepatic recognition

Explanation: As chylomicrons undergo lipolysis, the C apolipoproteins (apoC-II and apoC-III) are transferred to HDL particles, while the structural apolipoprotein apoB-48 remains on the particle. ApoE also remains on the remnant and is crucial for hepatic uptake via the LDL receptor-related protein. Choice A is incorrect because apoB-48 is the structural protein and cannot be transferred. Choice C is wrong because lipoprotein lipase hydrolyzes triglycerides, not proteins. Choice D is incorrect because apoE is acquired from HDL during chylomicron maturation, not synthesized de novo on the particle.